{
    "clinical_study": {
        "@rank": "114124", 
        "arm_group": [
            {
                "arm_group_label": "0.9% saline + oral placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "nebulized epinephrine + 0.9% saline + placebo => epinephrine + 0.9% saline"
            }, 
            {
                "arm_group_label": "3% saline + oral placebo", 
                "arm_group_type": "Experimental", 
                "description": "nebulized epinephrine + 3% saline + placebo => nebulized epinephrine + 3% saline"
            }, 
            {
                "arm_group_label": "0.9% saline + oral dexamethasone", 
                "arm_group_type": "Active Comparator", 
                "description": "nebulized epinephrine + 0.9% saline + dexamethasone => nebulized epinephrine + 0.9% saline"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a prospective, randomized, controlled, double-blinded, clinical trial\n\n      Subject : 3mo ~ 24mo. aged infants with bronchiolitis\n\n      The effect of 3 % NaCl nebulizer or dexamethasone on admission rate of these infants in ED."
        }, 
        "brief_title": "Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Bronchiolitis", 
        "condition_browse": {
            "mesh_term": [
                "Bronchiolitis", 
                "Emergencies"
            ]
        }, 
        "detailed_description": {
            "textblock": "Randomly assigned to one of three groups\n\n        -  Group I : nebulized epinephrine + 0.9% saline + placebo\n\n        -  Group II : nebulized epinephrine + 3% saline + placebo\n\n        -  Group III : nebulized epinephrine + 0.9% saline + dexamethasone\n\n      Group I received two treatments of nebulized epinephrine mixed 0.9% saline and a total of\n      six oral doses of placebo, group II received nebulized epinephrine mixed 3% saline and oral\n      placebo, and group III received nebulized epinephrine mixed 0.9% saline and oral\n      dexamethasone.\n\n      The primary outcome is hospital admission within 7 days after the day of enrollment"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  3mo ~ 24mo aged patients with bronchiolitis visit to emergency departments\n\n          -  RDAI score 4-15\n\n        Exclusion Criteria:\n\n          -  < 3mo, > 24mo\n\n          -  infants who had received oral or inhaled corticosteroids during the preceding 2 weeks\n\n          -  infants with a previous episode of wheezing or a diagnosis of asthma\n\n          -  any chronic cardiopulmonary disease\n\n          -  immunodeficiency\n\n          -  infants needed intubation\n\n          -  infants with a previous history of apnea or intubation\n\n          -  infants with side effect of dexamethasone\n\n          -  infants born at less than 37 weeks of gestation who had a corrected age of less than\n             6 weeks at presentation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "24 Months", 
            "minimum_age": "3 Months"
        }, 
        "enrollment": {
            "#text": "336", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01660867", 
            "org_study_id": "Bronchiolitis_1"
        }, 
        "intervention": [
            {
                "arm_group_label": "3% saline + oral placebo", 
                "description": "nebulized epinephrine + 3% saline + placebo => nebulized epinephrine + 3% saline", 
                "intervention_name": "3% saline + oral placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "0.9% saline + oral dexamethasone", 
                "description": "nebulized epinephrine + 0.9% saline + dexamethasone => nebulized epinephrine + 0.9% saline", 
                "intervention_name": "0.9% saline + oral dexamethasone", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Epinephrine", 
                "Dexamethasone", 
                "Dexamethasone acetate", 
                "Dexamethasone 21-phosphate", 
                "BB 1101"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "hospital admission within 7 days of 3% NaCl nebulizer vs dexamethasone", 
        "lastchanged_date": "August 8, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seongnam-si", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi-do", 
                    "zip": "463-707"
                }, 
                "name": "Seoul National University Bundang Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "3", 
        "official_title": "Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "hospital admission within 7 days after the day of enrollment(the initial visit to the emergency department)", 
            "measure": "hospital admission within 7 days after the day of enrollment", 
            "safety_issue": "No", 
            "time_frame": "within 7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01660867"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Jin Hee Lee", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "RDAI score", 
                "measure": "RDAI score", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, between nebulizer, 60min, 120min, 180min, 240min"
            }, 
            {
                "description": "respiratory rate", 
                "measure": "respiratory rate", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, between nebulizer, 60min, 120min, 180min, 240min"
            }, 
            {
                "description": "Heart rate", 
                "measure": "Heart rate", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, between nebulizer, 60min, 120min, 180min, 240min"
            }, 
            {
                "description": "Oxygen saturation", 
                "measure": "Oxygen saturation", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, between nebulizer, 60min, 120min, 180min, 240min"
            }, 
            {
                "description": "unplanned revisit admission rate after revisit", 
                "measure": "unplanned revisit and admission rate after revisit", 
                "safety_issue": "Yes", 
                "time_frame": "in 7days"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}